The EGFR is frequently activated by mutation and/or gene amplification in a variety of human cancers including lung, head and neck, breast, brain, and ovary, and EGFR-expressing tumours frequently evolve to express EGFR ligands (e.g. EGF; transforming growth factor alpha, TGFα) that further promotes their growth [2]. This evidence concerns the gene EGFR and cancer.